Emerging Role and Mechanism of circRNAs in Pediatric Malignant Solid Tumors

被引:1
作者
Shen, Qiyang [1 ]
Liu, Xingyu [2 ]
Li, Wei [3 ]
Zhao, Xu [2 ]
Li, Tao [1 ]
Zhou, Kai [2 ]
Zhou, Jianfeng [1 ]
机构
[1] Nanjing Med Univ, Childrens Hosp, Dept Pediat Surg, Nanjing, Peoples R China
[2] Bengbu Med Coll, Affiliated Hosp 1, Dept Pediat Surg, Bengbu, Peoples R China
[3] Nanjing Med Univ, Childrens Hosp, Dept ENT, Nanjing, Peoples R China
关键词
pediatric malignant solid tumors; circRNA; epigenetics; biomarkers; biological functions; B-CELL LYMPHOMA; CIRCULAR RNA; ADRENOCORTICAL CARCINOMA; PARENTAL GENE; NONCODING RNA; PROMOTES; PROGRESSION; RHABDOMYOSARCOMA; PROLIFERATION; EXPRESSION;
D O I
10.3389/fgene.2021.820936
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Circular RNAs (circRNAs) are non-coding RNAs with covalent closed-loop structures and are widely distributed in eukaryotes, conserved and stable as well as tissue-specific. Malignant solid tumors pose a serious health risk to children and are one of the leading causes of pediatric mortality. Studies have shown that circRNAs play an important regulatory role in the development of childhood malignant solid tumors, hence are potential biomarkers and therapeutic targets for tumors. This paper reviews the biological characteristics and functions of circRNAs as well as the research progress related to childhood malignant solid tumors.
引用
收藏
页数:13
相关论文
共 154 条
[1]   The non-coding RNA interactome in joint health and disease [J].
Ali, Shabana A. ;
Peffers, Mandy J. ;
Ormseth, Michelle J. ;
Jurisica, Igor ;
Kapoor, Mohit .
NATURE REVIEWS RHEUMATOLOGY, 2021, 17 (11) :692-705
[2]   Circular RNA in cardiovascular disease [J].
Altesha, M-Ashraf ;
Ni, Tiffany ;
Khan, Afaan ;
Liu, Kexiang ;
Zheng, Xiufen .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (05) :5588-5600
[3]   Origins of DNA methylation defects in Wilms tumors [J].
Anvar, Zahra ;
Acurzio, Basilia ;
Roma, Josep ;
Cerrato, Flavia ;
Verde, Gaetano .
CANCER LETTERS, 2019, 457 :119-128
[4]   Emerging therapeutic targets for neuroblastoma [J].
Aravindan, Natarajan ;
Herman, Terence ;
Aravindan, Sheeja .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (09) :899-914
[5]   Fifty years of rhabdomyosarcoma studies on both sides of the pond and lessons learned [J].
Arndt, Carola A. S. ;
Bisogno, Gianni ;
Koscielniak, Ewa .
CANCER TREATMENT REVIEWS, 2018, 68 :94-101
[6]   circRNA Biogenesis Competes with Pre-mRNA Splicing [J].
Ashwal-Fluss, Reut ;
Meyer, Markus ;
Pamudurti, Nagarjuna Reddy ;
Ivanov, Andranik ;
Bartok, Osnat ;
Hanan, Mor ;
Evantal, Naveh ;
Memczak, Sebastian ;
Rajewsky, Nikolaus ;
Kadener, Sebastian .
MOLECULAR CELL, 2014, 56 (01) :55-66
[7]   Immunosuppression in Medulloblastoma: Insights into Cancer Immunity and Immunotherapy [J].
Audi, Zahraa F. ;
Saker, Zahraa ;
Rizk, Mahdi ;
Harati, Hayat ;
Fares, Youssef ;
Bahmad, Hisham F. ;
Nabha, Sanaa M. .
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (09)
[8]   Adjuvant Therapy in Adrenocortical Carcinoma: Reflections and Future Directions [J].
Bedrose, Sara ;
Daher, Marilyne ;
Altameemi, Lina ;
Habra, Mouhammed Amir .
CANCERS, 2020, 12 (02)
[9]   The quest to develop an effective therapy for neuroblastoma [J].
Bhoopathi, Praveen ;
Mannangatti, Padmanabhan ;
Emdad, Luni ;
Das, Swadesh K. ;
Fisher, Paul B. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (11) :7775-7791
[10]   The Tumor Microenvironment in Neuroblastoma: New Players, New Mechanisms of Interaction and New Perspectives [J].
Blavier, Laurence ;
Yang, Ren-Ming ;
DeClerck, Yves A. .
CANCERS, 2020, 12 (10) :1-18